Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Antoxerene Logo
Antoxerene Growth Score
33
CB Rank
183445
Heat Score
11
Antoxerene, Inc. is a pharmaceutical company
Founded
obfuscation
PrivateSeed Lafayette, Louisiana, United States11-50 antoxerene.com/
Biotechnology
Health Care
Pharmaceutical
Overview

Antoxerene
Total Funding
obfuscation
Growth Score
33
Heat Score
11

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score33
-2 pts
in past quarter
Heat Score 11
-23 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Antoxerene

CB Rank
183445
Antoxerene, Inc. is a pharmaceutical company
Founded
obfuscation
PrivateSeed Lafayette, Louisiana, United States11-50 antoxerene.com/
Biotechnology
Health Care
Pharmaceutical

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name Antoxerene, Inc.
Operating Status Active
Company Type For Profit
Founders  Adam Blanden
About the Company
This is a pharmaceutical company that uses proprietary next generation screening technology to identify small molecule drugs for pathways of aging. It is an affiliate of Ichor Therapeutics. Antoxerene is eager to engage collaborators in industry and academia who share its vision of delivering next generation therapies for the illnesses of aging.
Phone Number +1 518 420 5004
Contact Email info@ichortherapeutics.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Lysoclear
A recombinant enzyme therapy targeting retinoid derivatives associated with eye diseases.
Auctus Biologics, Inc.
Develops an orally bioavailable antibody mimetic scaffold known as a ribobody.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Antoxerene Logo
Seed Round - Antoxerene
3
obfuscation
KIZOO Technology CapitalSeed
obfuscation
Seed Round - Antoxerene Logo
Seed Round - Antoxerene
3
obfuscation
KIZOO Technology CapitalSeed
obfuscation
Seed Round - Antoxerene Logo
Seed Round - Antoxerene
3
obfuscation
KIZOO Technology CapitalSeed
obfuscation
Seed Round - Antoxerene Logo
Seed Round - Antoxerene
3
obfuscation
KIZOO Technology CapitalSeed
obfuscation
Seed Round - Antoxerene Logo
Seed Round - Antoxerene
3
obfuscation
KIZOO Technology CapitalSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Antoxerene Logo
Seed Round - Antoxerene
3
obfuscation
KIZOO Technology CapitalSeed
obfuscation
Seed Round - Antoxerene Logo
Seed Round - Antoxerene
3
obfuscation
KIZOO Technology CapitalSeed
obfuscation
Seed Round - Antoxerene Logo
Seed Round - Antoxerene
3
obfuscation
KIZOO Technology CapitalSeed
obfuscation
Seed Round - Antoxerene Logo
Seed Round - Antoxerene
3
obfuscation
KIZOO Technology CapitalSeed
obfuscation
Seed Round - Antoxerene Logo
Seed Round - Antoxerene
3
obfuscation
KIZOO Technology CapitalSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2

Employee Profiles

News
Technology
View Tech Report

Active Website Tech Count

7Antoxerene is actively using 7 technologies for its website, according to BuiltWith. These include OpenResty, GoDaddy CDN, and  Google Adsense.
Sub-Organizations
Frequently Asked Questions

Where is Antoxerene's headquarters? Antoxerene is located in Lafayette, Louisiana, United States.Who invested in Antoxerene? Antoxerene has 3 investors including KIZOO Technology Capital and  SENS Foundation.When was the last funding round for Antoxerene? Antoxerene closed its last funding round on
obfuscation
from a Seed round.Who are Antoxerene's competitors? Alternatives and possible competitors to Antoxerene may include BioAge Labs, Maze Therapeutics, and  Nimbus Therapeutics.How much funding has Antoxerene raised to date? Antoxerene has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|